DARWIN PRECISIONS’ New Factory Goes into Mass Production, Biomedical Business Set to Take Off Next Year

DARWIN PRECISIONS Chairman Kuo-Hsin Tsai is driving the company’s transformation by investing in technology R&D and establishing new ventures. This year, the Taichung Daya plant has been converted into a biomedical R&D and manufacturing hub, shifting its focus from panels to face masks. DARWIN’s subsidiary, Shine Biomedical Technology, inaugurated its new factory, aiming for a monthly output of 5 million face masks in 2026, while micro-needle business from MicroDoctor Biomedical is expected to start contributing to profits.